OpenAlex
PricingAboutJobs
Log inGet started
Work

CDK4/6 Inhibition in Breast Cancer: Mechanisms of Response and Treatment Failure

HTML

Year: 2017
Type: article
Source: Current Breast Cancer Reports
DOI: 10.1007/s12609-017-0232-0
Authors: Ana C. Garrido-Castro, Shom Goel
Institution: Dana-Farber Cancer Institute
Language: English

Topic: Advanced Breast Cancer Therapies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: CDK4/6 inhibitors, breast cancer, D-type cyclins, cyclin D1, p16, Rb loss, treatment resistance, treatment response biomarkers, therapeutic combinations
SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute
Awards: G1022870368, Dana Farber/Harvard Cancer Center Specialized Program of Research Excellence in Breast Cancer
OpenAlex ID: W2583538213
FWCI: 4.055
Cites: 65
Cited by: 72
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security